Cancerbackup: Q-73955451

Skip the page content navigation if you do not require links to content sections within this page.

Page Content Navigation

Skip the main banner if you do not want to read it as the next section.


Page Banner

Want to speak to a specialist cancer nurse? Call free on 0808 800 1234


Skip the primary navigation if you do not want to read it as the next section.


Primary navigation


Skip the secondary navigation if you do not want to read it as the next section.


Secondary Navigation

Alison Do you want to meet other people with cancer? Join our What Now? community >>

Skip the main content if you do not want to read it as the next section.


Are phaeochromocytomas inherited?

Phaeochromocytomas are a type of tumour that develops in the adrenal glands. These are small glands that sit on top of the kidneys, and produce a number of different hormones. 9 out 10 phaeochromocytomas are benign (non-cancerous), but about 1 in 10 is a cancer.

Most phaeochromocytomas are not linked to an inherited condition (these are called sporadic tumours). However, it has recently been realised that up to 1 in 3 phaeochromocytomas may be the result of inheriting a faulty gene. There are a number of faulty genes that may be involved. Any one of them can lead to an increased risk of phaeochromocytoma.

These faulty genes are linked to several different familial conditions.

  • Multiple endocrine neoplasia 2. About half the people affected develop a phaeochromocytoma.
  • Von Hippel Lindau syndrome. About 1 in 15 people affected develops a phaeochromocytoma.
  • Neurofibromatosis type 1 (NF1). Affects about 1 in 3000 people. It causes coffee coloured patches on the skin and benign tumours of the nerves. About 1 in 100 people with NF1 develops a phaeochromocytoma.
  • Familial phaeochromocytoma. Causes no other signs of illness. It may be linked to between a quarter and a third of cases of phaeochromocytoma.

With the exception of tumours linked to NF1, phaeochromocytomas caused by inheriting a faulty gene, tend to occur at a younger age than sporadic cases. Because of this it has been suggested that anyone under the age of 50, who develops a phaeochromocytoma, should be offered genetic testing.

References

  • Pheochromocytoma: the Expanding Genetic Differential Diagnosis Bryant J et al. JNCI 95(16) 2003
  • Evolving concepts in pheochromocytoma and paraganglioma. Dahia P. Current Opinion in Oncology 18:1-8 2006

Related Q&A


Content last reviewed: 04 May 2006
Page last modified: 13 June 2008

The best cancer information for everyone
Cancerbackup has merged with Macmillan Cancer Support. We will be providing the same high quality, expertly developed information about cancer and now we can make it available to everyone who needs it.